News and Media

NEWS AND MEDIA

The latest news from HEMA Biologics

The latest news from HEMA Biologics

  • FDA accepts the submitted Biologic License Application for Coagulation Factor VIIa (Recombinant), activated eptacog beta.

    LOUISVILLE, Ky., Jan. 9, 2017 /PRNewswire/ -- HEMA Biologics, LLC announced that the FDA has accepted the BLA for their first potential product for commercialization in the United States.

    Read more


  • HEMA Biologics participates in local hemophilia walks

    Stop by and say hi if you plan to be a part of these walks. We’d love to meet you!

    Miami April
    New York City June
    Portland June
    Denver August
    Detroit August
    Las Vegas September
    Washington, DC October
    Louisville October
    Los Angeles November

  • HEMA Biologics heading to Providence, RI for the HFA annual meeting

    We look forward to being at HFA and meeting the community. If you plan to attend, visit us at Booth 16.

    Read more